Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bladder cancer, Kidney cancer
Closed
Phase 2
This trial is for people with urothelial (urinary tract) cancer that has spread to somewhere else in the body.
It is looking at adding radiotherapy to a drug called atezolizumab. The team want to find out if it works better than ateolizumab on its own.
Cancer Research UK supports this trial.
Recruitment start: 15 September 2021
Recruitment end: 8 February 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Huddart
Cancer Research UK
Institute of Cancer Research (ICR)
National Institute for Health Research (NIHR)
Roche
This is Cancer Research UK trial number CRUKE/19/009.
Last reviewed: 6 March 2024
CRUK internal database number: 17241
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
